ClinicalTrials.gg
Active, not recruitingNCT07803302Updated Sep 3, 2026

Pelvic Stabilization Belt Combined With Exercise Therapy on Pelvic Girdle Pain and Mobility in Post-partum Women

An interventional study of Pelvic Stabilization Belt and Standard Pelvic Floor Physical Therapy in Pelvic Girdle Pain, sponsored by University of Lahore. Active, not recruiting at 1 site in Pakistan. Open to female participants aged 22 Years to 45 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-09-03.

Sponsored by University of Lahore · Not applicable, Interventional, and Treatment

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
56
Allocation
Randomized
Ages
22 Years to 45 Years
Sex
Female
01

Where this study stands

Counted across the records on this site · 2026-11-13

Among 13 studies in Pelvic Girdle Pain with a site in Pakistan — 2 open to participants now, 4 under way, none of them phase 3. Pelvic Girdle Pain · Pakistan.

Enrollment
2nd of 11
56 · median 40
Started
2026
the only one that year
No phase
11 of 13
2 open now
Registered
13th of 13
by date
Lead sponsor
1 of 13
University of Lahore

Among the 13 studies in Pelvic Girdle Pain with a site in Pakistan, this one is the 2nd largest by enrollment of the 11 interventional ones that give a count, is the only one that started in 2026, is one of 11 with no phase, and was the 13th registered.

Pelvic Girdle Pain

63 studies on the registry are indexed under Pelvic Girdle Pain; 14 are open to participants now.

Browse Pelvic Girdle Pain studies →

Open to participants now

2 of the 13 studies in Pelvic Girdle Pain with a site in Pakistan are open now. Recruiting first, the newest first:

All 2 open studies →

A study can be open while its sites in Pakistan have not opened yet or have stopped. Only those recruiting at a site in Pakistan →

Who these studies take

Of the 11 Pelvic Girdle Pain studies recruiting now, 3 (27%) set no upper age limit and 8 (73%) stop at 75 or younger; 1 takes children under 18; 5 take healthy volunteers.

This study: 22 Years to 45 Years · female · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Watch this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 13 studies in Pelvic Girdle Pain with a site in Pakistan, or all of them as a file.
02

Study summary

This randomized controlled trial aims to evaluate the effects of a pelvic stabilization belt combined with exercise therapy on pelvic girdle pain and mobility in postpartum women. The study will compare combined pelvic stabilization belt and exercise therapy with exercise therapy alone. Pain, functional mobility, and pelvic girdle-related disability will be assessed to determine whether adding a pelvic stabilization belt provides additional benefits for postpartum women experiencing pelvic girdle pain.

03

Conditions studied

  • Pelvic Girdle Pain

Browse trials for

Keywords

  • Pelvic Girdle Pain
  • Postpartum women
  • Exercise Therapy
  • Orthotic Devices
  • Physical Therapy
04

Who can participate

Ages eligible
22 Years to 45 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

    • Age between 22-45 years.(Yang et al., 2026)

      • Postpartum duration of 6 weeks to 6 months after delivery.(Yang et al., 2026)
      • Postpartum women diagnosed with pelvic girdle pain using diagnostic test P4 and ASLR.(Jafarian et al., 2025)
      • Presence of pelvic pain affecting functional activities such as walking, standing, or changing position.
      • Ability to understand instructions and perform basic mobility tasks.
      • Willingness to participate and provide .(Meah et al., 2020)

Exclusion criteria

Exclusion Criteria:

  • A clinical diagnosis of any mental disorder.(Hirsch et al., 2021)
  • Severe psychiatric or cognitive disorders affecting compliance with exercise and follow-up.(Jafarian et al., 2025)
  • Previous spinal surgery or severe lumbar spine pathology that overlaps with pelvic pain presentation.(Gutke et al., 2021)
  • Rheumatological or inflammatory joint diseases such as ankylosing spondylitis.
  • Current pregnancy during the study period, due to hormonal and biomechanical changes affecting pelvic stability.
  • Any condition requiring urgent medical or surgical intervention unrelated to musculoskeletal dysfunction
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
56 participants (actual)

Study arms

  • Experimental
    Pelvic Stabilization Belt + Exercise Therapy

    Participants will receive a pelvic stabilization belt combined with standard pelvic floor physical therapy for 4 weeks. The belt will be worn for at least 4 hours per day during functional activities such as walking, standing, household work, and childcare, positioned around the pelvic ring at the level of the greater trochanters. Standard therapy will include patient education on spinal stability, lumbopelvic alignment, posture, ergonomics, infant care, gait, and psychological support, along with pelvic floor muscle training (Kegel exercises).

    Device: Pelvic Stabilization Belt · Behavioral: Standard Pelvic Floor Physical Therapy

  • Active comparator
    Exercise Therapy Only

    Participants will receive standard pelvic floor physical therapy for 4 weeks without use of a pelvic stabilization belt. Treatment will include patient education on spinal stability, lumbopelvic alignment, posture, ergonomics, breastfeeding and infant handling, gait training, and psychological support, along with pelvic floor muscle training (Kegel exercises) consisting of 5-10 second contractions, 10-15 repetitions per set, and 3-4 sets per day.

    Device: Pelvic Stabilization Belt · Behavioral: Standard Pelvic Floor Physical Therapy

Interventions

  • DevicePelvic Stabilization Belt

    Participants assigned to the experimental group will use a pelvic stabilization belt in addition to standard pelvic floor physical therapy for 4 weeks. The belt will be positioned around the pelvic ring at the level of the greater trochanters to provide pelvic compression and support pelvic stability. Participants will be instructed to wear the belt for at least 4 hours per day during functional activities, including walking, standing, household work, and childcare activities.

  • BehavioralStandard Pelvic Floor Physical Therapy

    Participants in both groups will receive standard pelvic floor physical therapy for 4 weeks. Treatment will include patient education regarding spinal stability, lumbopelvic alignment, posture, ergonomic strategies for breastfeeding, lifting and infant care, gait training, and psychological support. Pelvic floor muscle training will include Kegel exercises performed in supine or seated positions, with 5-10-second contractions, 10-15 repetitions per set, and 3-4 sets per day, emphasizing isolated pelvic floor muscle activation without compensatory abdominal or gluteal contraction.

06

What researchers measure

Primary outcomes

  1. Pelvic girdle pain

    The Visual Analog Scale (VAS) will be used to assess pelvic girdle pain intensity. It consists of a 10-cm horizontal line ranging from 0 (no pain) to 10 (worst imaginable pain). Participants will mark the point that best represents their current pain intensity. Higher scores indicate greater pain severity.

    Time frame: 4 weeks

07

Study locations

1 site
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Aug 2026 (actual). Primary completion is estimated for Dec 2026, 4 months after the start.

Of 32 interventional studies with no phase under Pelvic Girdle Pain, half reached primary completion within 10 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 59. This study's planned 4 months is below that.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 27, 2026
First posted
Sep 3, 2026
StartActual
Aug 22, 2026
Primary completionEst.
Dec 2026
CompletionEst.
Dec 2026
Last update
Sep 3, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 3, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT07803302
Responsible party
Quratulain Amir Rashid Butt (Dr Qurat ul Ain, University of Lahore) — Principal investigator
First posted
Sep 3, 2026
Start date
Aug 22, 2026
Primary completion
Dec 2026 (estimated)
Completion
Dec 2026 (estimated)
Last update
Sep 3, 2026

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion